Misbah Tahir
Vermogen: - $ op 30-06-2026
Vermogen: - $ op 30-06-2026
Misbah Tahir is currently Chief Financial & Accounting Officer at Maze Therapeutics, Inc. since 2026.
Formerly, served as Chief Financial Officer at IGM Biosciences, Inc. from 2019 to 2025.
Previously, was Vice President & Head-Finance at Dermira, Inc. from 2014 to 2018.
Education includes undergraduate studies at the University of Pennsylvania and an MBA from Stephen M.
Ross School of Business.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases -.--% | 31-03-2026 | 0 ( -.--% ) | - $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases | Financieel Directeur/CFO | 02-09-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
| IGM BIOSCIENCES, INC. | Financieel Directeur/CFO | 01-08-2025 |
| DERMIRA, INC. | Corporate Officer/Principal | 01-12-2018 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stephen M. Ross School of Business
Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dermira, Inc.
Dermira, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to patients living with chronic skin conditions | Health Technology |
IGM Biosciences, Inc.
IGM Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops engineered IgM antibodies for the treatment of cancer patients | Health Technology |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau